Nyxoah Sa Asset Turnover Ratio (NYXH), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nyxoah Sa  (NASDAQ: NYXH)
 

Nyxoah Sa Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Nyxoah Sa asset turnover ratio, the ability of Nyxoah Sa's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.09 in the fourth quarter (Dec 31 2025), yet the ratio remained below the average, as NYXH's position remain challenging.

Within sector 187 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3855.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NYXH Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -25.21 % -25.21 % -23.85 % -25.21 % 29.18 %
Y / Y Revenue Change 156.29 % - 82.96 % - 258.85 %
Asset Turnover Ratio (TTM) 0.09 - 0.04 - 0.03
NYXH's Total Ranking # 3855 # 0 # # #
Seq. Asset Change 0 % -1.79 % 1.82 % -25.21 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 188
Healthcare Sector # 572
Overall Market # 3855

Asset Turnover Ratio Statistics
High Average Low
0.8 0.8 0.8
(Dec 31 2025)  




NYXH Company Profile • Back to NYXH Efficiency Comparisons • Compare NYXH Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Hyperfine Inc   0.26 $ 12.753  Millions$ 48.846  Millions
Innovative Eyewear Inc   0.26 $ 2.662  Millions$ 10.298  Millions
Bio rad Laboratories Inc   0.26 $ 2,582.900  Millions$ 10,003.475  Millions
Theravance Biopharma inc   0.26 $ 107.464  Millions$ 417.662  Millions
Retractable Technologies Inc  0.25 $ 37.314  Millions$ 146.366  Millions
Repligen Corp  0.25 $ 738.256  Millions$ 2,906.795  Millions
Nutriband Inc   0.25 $ 2.037  Millions$ 8.074  Millions
Ars Pharmaceuticals Inc   0.25 $ 84.278  Millions$ 335.311  Millions
Personalis Inc   0.25 $ 69.648  Millions$ 277.248  Millions
Neogen Corporation  0.25 $ 880.774  Millions$ 3,575.541  Millions
Ispecimen inc   0.25 $ 1.929  Millions$ 7.852  Millions
Jaguar Health Inc   0.25 $ 11.511  Millions$ 46.881  Millions
Icecure Medical Ltd  0.24 $ 3.379  Millions$ 13.888  Millions
Biolife Solutions Inc   0.24 $ 96.118  Millions$ 395.087  Millions
Onemednet Corporation  0.24 $ 0.461  Millions$ 1.932  Millions
Insmed Inc  0.23 $ 522.628  Millions$ 2,226.972  Millions
Cryoport inc   0.23 $ 176.177  Millions$ 753.272  Millions
Revvity Inc  0.23 $ 2,856.051  Millions$ 12,257.719  Millions
Zomedica Corp   0.23 $ 31.278  Millions$ 134.352  Millions
Arcus Biosciences Inc   0.23 $ 247.000  Millions$ 1,086.000  Millions
Enanta Pharmaceuticals Inc  0.23 $ 66.980  Millions$ 296.372  Millions
Volitionrx Limited  0.23 $ 1.727  Millions$ 7.644  Millions
Celularity Inc   0.23 $ 26.550  Millions$ 117.682  Millions
Cellectis S a   0.22 $ 72.949  Millions$ 324.720  Millions
Xortx Therapeutics inc   0.22 $ 0.596  Millions$ 2.684  Millions
China Pharma Holdings Inc  0.22 $ 4.144  Millions$ 18.697  Millions
Collplant Biotechnologies Ltd  0.22 $ 2.371  Millions$ 10.785  Millions
Ligand Pharmaceuticals Incorporated  0.22 $ 268.087  Millions$ 1,222.862  Millions
Lexicon Pharmaceuticals Inc   0.22 $ 49.803  Millions$ 228.542  Millions
Gossamer Bio Inc   0.21 $ 48.471  Millions$ 225.646  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.